Mantle Cell Lymphoma

Ultima Vez Modificado: 28 de septiembre del 2006

Translation for this article does not exist


7 Tips for Giving Smart on #givingtuesday
by Christina Bach, MSW, LCSW, OSW-C
November 25, 2015

Related News

FDA Approves Imbruvica for Mantle Cell Lymphoma

Nov 14, 2013

Drug designed to inhibit enzyme that cancer cells need to spread; granted "breakthrough therapy" status

Ibrutinib Active in Refractory or Relapsed Mantle-Cell Lymphoma

Jun 20, 2013

Response rate of 68 percent; estimated rate of overall survival, 58 percent at 18 months

R-CHOP Benefits Older Mantle-Cell Lymphoma Patients

Aug 9, 2012

Improved survival for older patients with R-CHOP induction, rituximab maintenance treatment